GlaxoSmithKline has asked for the approval of India's Foreign Investment Promotion Board for its planned acquisition of a 24.33% stake in its Indian arm GlaxoSmithKline Pharmaceuticals Ltd. GSK will fund the stake hike by investing INR6,400 crore.
Medical
UK medical device maker Lombard Medical to pursue IPO in the US
England, UK-based specialty medical device maker Lombard Medical Technologies PLC plans to pursue an initial public offering (IPO) and listing of ordinary shares in the US.
CEN Biotech invests $12M for medical marijuana facility in Lakeshore
US-based contract research firm CEN Biotech will invest $12 million to build a high-security medical marijuana facility in Lakeshore, Canada in a bid to start a new industry in the region.
US genomics startup Omicia picks up $6.8M in Series A round
California, US-based clinical genomic startup Omicia has raised $6.8 million in a Series A round led by Artis Ventures for the expansion of its marketing efforts and optimization of its big data offerings.
Forest Laboratories nears $3B takeover deal of Aptalis
Forest Laboratories is close to an agreement to buy New Jersey-based specialty pharmaceutical company Aptalis Holdings from private equity firm TPG Capital. Forest will pay $3 billion for Aptalis.
Latest News
California, US-based genomics startup DNAnexus raised $15 million to develop its cloud-based platform for storage and analysis of large amounts of DNA data, bringing its total funding to date to $31.6 million.
North Carolina, US-based diagnostic and research service provider Metabolon Inc announced that it has closed $15 million in Series E financing through preferred stock issuance.
Cyprotex, a drug testing company based in the UK, on Thursday announced that it had purchased American rival CeeTox. Cyprotex will initially pay £630,000 to the North American Science Associates for CeeTox.
Zyden Gentec Ltd.'s shares fell by 5% to INR15.25 per share after Punjab National Bank's recent stake sale. PNB had sold 335,141 of its shares in the pharmaceutical company, which represents a 3% equity ownership.
Rhoen-Klinukum, which had put up for sale its 43 hospitals and 15 outpatient facilities, expects to get the green light from German antitrust regulators on the proposed sale of most of its assets to rival Fresenius SE & Co.
Hedge fund Elliott International, which owns a 25.16% stake in Celesio, said that reports suggesting it will accept McKesson Corporation's $8.3 billion bid for the German drugs wholesaler are incorrect. Elliott had irrevocably rejected McKesson's offer, saying that it undervalues Celesio.
Private equity firm Blackstone Group has put up for sale its 13.09% stake in Indian drug company Emcure Pharmaceuticals. The stake will be sold to rival private equity firm Bain Capital for INR650 crore.
Private equity firm Carlyle Group has acquired a minority stake of 28% in Indian super-specialty hospital chain Global Health for INR960 crore. Carlyle as of September this year had invested $1.1 billion in India.
The Ohio Third Frontier Commission has awarded Synapse Biomedical with $2.4 million to further the design and development of its NeuRx technology, a platform that is used to treat patients with respiratory insufficiency.
